By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


HemoGenix Inc. 

4405 N. Chestnut Street
Suite D
Colorado Springs  Colorado  80907  U.S.A.
Phone: 719-264-6250 Fax: 719-264-6253



Company News
HemoGenix Inc. Announces A Major Advancement To Promote Best Practices In Umbilical Cord Blood Testing And Patient Transplant Outcomes 8/7/2014 9:53:37 AM
HemoGenix Inc. Announces Publication of its White Paper on "Stem Cells and Predictive in Vitro Toxicity Testing" 11/18/2011 9:45:57 AM
Vitro Diagnostics (VODG) Launches New Stem Cell Products for Clinical Use & Presents Webinar with HemoGenix Inc. 7/20/2011 8:30:22 AM
Vitro Diagnostics (VODG) Expands HemoGenix Inc. Alliance to Include Cell-based Testing for Liver Toxicity 10/19/2010 10:04:00 AM
Vitro Diagnostics (VODG) and HemoGenix Inc. Launch New Products at an International Stem Cell Meeting 6/15/2010 10:15:26 AM
Vitro Diagnostics (VODG) Forms Strategic Alliance With a Leading Stem Cell Company HemoGenix Inc. 4/28/2010 11:07:13 AM
HemoGenix Inc. Receives Issued Patent for its HALO(R) Technology Platform 4/9/2008 10:48:22 AM
ImmuneRegen BioSciences, Inc. (IRBO) Announces Material Transfer Agreement with HemoGenix Inc. 1/28/2008 9:25:53 AM
HemoGenix Inc. Introduces HALO(R)-96 PQR, the First Stem Cell Potency and Release Assay to Incorporate a Reference Standard 12/5/2007 12:56:09 PM
HemoGenix LLC Launches HALO(TM) 384HT, The First Ever High Throughput Predictive Stem Cell Hemotoxicity Screening Platform 6/22/2006 1:41:11 PM